These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25266821)

  • 1. Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction.
    Le Foll B; Di Ciano P
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1401-9. PubMed ID: 25266821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine D3 receptor, a quarter century later.
    Sokoloff P; Le Foll B
    Eur J Neurosci; 2017 Jan; 45(1):2-19. PubMed ID: 27600596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.
    Le Foll B; Collo G; Rabiner EA; Boileau I; Merlo Pich E; Sokoloff P
    Prog Brain Res; 2014; 211():255-75. PubMed ID: 24968784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of dopamine D3 receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in rats.
    Xi ZX; Li X; Li J; Peng XQ; Song R; Gaál J; Gardner EL
    Addict Biol; 2013 Jul; 18(4):665-77. PubMed ID: 22913325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.
    Wager TT; Chappie T; Horton D; Chandrasekaran RY; Samas B; Dunn-Sims ER; Hsu C; Nawreen N; Vanase-Frawley MA; O'Connor RE; Schmidt CJ; Dlugolenski K; Stratman NC; Majchrzak MJ; Kormos BL; Nguyen DP; Sawant-Basak A; Mead AN
    ACS Chem Neurosci; 2017 Jan; 8(1):165-177. PubMed ID: 27715007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design.
    Keck TM; Burzynski C; Shi L; Newman AH
    Adv Pharmacol; 2014; 69():267-300. PubMed ID: 24484980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence.
    Heidbreder C
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):410-21. PubMed ID: 19128200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO.
    Boileau I; Nakajima S; Payer D
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of chronic THC on the neuroadaptive response of dopamine D2/3 receptor-mediated signaling in roman high- and roman low-avoidance rats.
    Tournier BB; Dimiziani A; Tsartsalis S; Millet P; Ginovart N
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29265497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.
    Neisewander JL; Cheung TH; Pentkowski NS
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):301-19. PubMed ID: 23973315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine D3 receptor and drug dependence: effects on reward or beyond?
    Le Foll B; Goldberg SR; Sokoloff P
    Neuropharmacology; 2005 Sep; 49(4):525-41. PubMed ID: 15963538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.
    Boileau I; Payer D; Houle S; Behzadi A; Rusjan PM; Tong J; Wilkins D; Selby P; George TP; Zack M; Furukawa Y; McCluskey T; Wilson AA; Kish SJ
    J Neurosci; 2012 Jan; 32(4):1353-9. PubMed ID: 22279219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D3 receptors in the basolateral amygdala and the lateral habenula modulate cue-induced reinstatement of nicotine seeking.
    Khaled MA; Pushparaj A; Di Ciano P; Diaz J; Le Foll B
    Neuropsychopharmacology; 2014 Dec; 39(13):3049-58. PubMed ID: 24998621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs.
    Pich EM; Collo G
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1437-47. PubMed ID: 26298833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.
    Paterson LM; Flechais RS; Murphy A; Reed LJ; Abbott S; Boyapati V; Elliott R; Erritzoe D; Ersche KD; Faluyi Y; Faravelli L; Fernandez-Egea E; Kalk NJ; Kuchibatla SS; McGonigle J; Metastasio A; Mick I; Nestor L; Orban C; Passetti F; Rabiner EA; Smith DG; Suckling J; Tait R; Taylor EM; Waldman AD; Robbins TW; Deakin JF; Nutt DJ; Lingford-Hughes AR;
    J Psychopharmacol; 2015 Sep; 29(9):943-60. PubMed ID: 26246443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.
    Ferré S; Diamond I; Goldberg SR; Yao L; Hourani SM; Huang ZL; Urade Y; Kitchen I
    Prog Neurobiol; 2007 Dec; 83(5):332-47. PubMed ID: 17532111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO.
    Payer D; Balasubramaniam G; Boileau I
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():4-8. PubMed ID: 23999545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.
    Grundt P; Prevatt KM; Cao J; Taylor M; Floresca CZ; Choi JK; Jenkins BG; Luedtke RR; Newman AH
    J Med Chem; 2007 Aug; 50(17):4135-46. PubMed ID: 17672446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.
    Heidbreder CA; Gardner EL; Xi ZX; Thanos PK; Mugnaini M; Hagan JJ; Ashby CR
    Brain Res Brain Res Rev; 2005 Jul; 49(1):77-105. PubMed ID: 15960988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Perspectives on Selective Dopamine D
    Newman AH; Xi ZX; Heidbreder C
    Curr Top Behav Neurosci; 2023; 60():157-201. PubMed ID: 35543868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.